MA25832A1 - Sel de tartrate d'un derive de thiazolidinedione. - Google Patents

Sel de tartrate d'un derive de thiazolidinedione.

Info

Publication number: MA25832A1
Authority: MA; Morocco
Prior art keywords: tartrate; salt; thiazolidinedione derivative; thiazolidinedione; derivative
Prior art date: 2000-08-04

Application number

MA27024A

Other languages

English (en)

Inventor

Andrew Simon Graig

Tim Chien Ting Ho

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-04

Filing date

2003-02-03

Publication date

2003-07-01

2003-02-03 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2003-07-01 Publication of MA25832A1 publication Critical patent/MA25832A1/fr

Links

FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 title 1
150000003839 salts Chemical class 0.000 title 1
229940095064 tartrate Drugs 0.000 title 1
150000001467 thiazolidinediones Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Obesity (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Apparatus For Disinfection Or Sterilisation (AREA)
Cosmetics (AREA)

MA27024A 2000-08-04 2003-02-03 Sel de tartrate d'un derive de thiazolidinedione. MA25832A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0019224.5A GB0019224D0 (en)	2000-08-04	2000-08-04	Novel pharmaceutical

Publications (1)

Publication Number	Publication Date
MA25832A1 true MA25832A1 (fr)	2003-07-01

Family

ID=9897026

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA27024A MA25832A1 (fr)	2000-08-04	2003-02-03	Sel de tartrate d'un derive de thiazolidinedione.

Country Status (36)

Country	Link
US (1)	US20040014790A1 (fr)
EP (1)	EP1305311B1 (fr)
JP (1)	JP2004505970A (fr)
KR (1)	KR100755174B1 (fr)
CN (1)	CN1455778A (fr)
AP (1)	AP1785A (fr)
AT (1)	ATE384059T1 (fr)
AU (1)	AU2001276506A1 (fr)
BG (1)	BG107604A (fr)
BR (1)	BR0112982A (fr)
CA (1)	CA2417827A1 (fr)
CY (1)	CY1107252T1 (fr)
CZ (1)	CZ2003313A3 (fr)
DE (1)	DE60132461T2 (fr)
DK (1)	DK1305311T3 (fr)
DZ (1)	DZ3418A1 (fr)
EA (1)	EA005408B1 (fr)
EC (1)	ECSP034467A (fr)
ES (1)	ES2296772T3 (fr)
GB (1)	GB0019224D0 (fr)
HR (1)	HRP20030068B1 (fr)
HU (1)	HUP0300778A3 (fr)
IL (2)	IL154275A0 (fr)
MA (1)	MA25832A1 (fr)
MX (1)	MXPA03001085A (fr)
NO (1)	NO324596B1 (fr)
NZ (1)	NZ524030A (fr)
OA (1)	OA12354A (fr)
PL (1)	PL360662A1 (fr)
PT (1)	PT1305311E (fr)
SI (1)	SI1305311T1 (fr)
SK (1)	SK1462003A3 (fr)
UA (1)	UA76720C2 (fr)
WO (1)	WO2002012232A1 (fr)
YU (1)	YU14603A (fr)
ZA (1)	ZA200300961B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
USRE39384E1 (en)	1993-09-01	2006-11-07	Smithkline Beecham P.L.C.	Substituted thiazolidinedione derivatives
DE102005034406A1 (de) *	2005-07-22	2007-02-01	Ratiopharm Gmbh	Neue Salze von Rosiglitazon
US7435741B2 (en) *	2006-05-09	2008-10-14	Teva Pharmaceutical Industries, Ltd.	2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
EP3367946B1 (fr)	2015-10-27	2020-07-08	Nanopass Technologies Ltd.	Dispositif à micro-aiguilles avec guide mécanique

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds

2000
- 2000-08-04 GB GBGB0019224.5A patent/GB0019224D0/en not_active Ceased
2001
- 2001-03-08 UA UA2003020938A patent/UA76720C2/uk unknown
- 2001-08-03 SK SK146-2003A patent/SK1462003A3/sk unknown
- 2001-08-03 SI SI200130808T patent/SI1305311T1/sl unknown
- 2001-08-03 IL IL15427501A patent/IL154275A0/xx active IP Right Grant
- 2001-08-03 US US10/343,845 patent/US20040014790A1/en not_active Abandoned
- 2001-08-03 BR BR0112982-1A patent/BR0112982A/pt not_active IP Right Cessation
- 2001-08-03 KR KR1020037001604A patent/KR100755174B1/ko not_active Expired - Fee Related
- 2001-08-03 EA EA200300230A patent/EA005408B1/ru not_active IP Right Cessation
- 2001-08-03 AP APAP/P/2003/002736A patent/AP1785A/en active
- 2001-08-03 CA CA002417827A patent/CA2417827A1/fr not_active Abandoned
- 2001-08-03 PT PT01954159T patent/PT1305311E/pt unknown
- 2001-08-03 OA OA1200300028A patent/OA12354A/en unknown
- 2001-08-03 WO PCT/GB2001/003511 patent/WO2002012232A1/fr not_active Ceased
- 2001-08-03 HR HR20030068A patent/HRP20030068B1/xx not_active IP Right Cessation
- 2001-08-03 ES ES01954159T patent/ES2296772T3/es not_active Expired - Lifetime
- 2001-08-03 AT AT01954159T patent/ATE384059T1/de not_active IP Right Cessation
- 2001-08-03 PL PL36066201A patent/PL360662A1/xx not_active Application Discontinuation
- 2001-08-03 DK DK01954159T patent/DK1305311T3/da active
- 2001-08-03 MX MXPA03001085A patent/MXPA03001085A/es active IP Right Grant
- 2001-08-03 AU AU2001276506A patent/AU2001276506A1/en not_active Abandoned
- 2001-08-03 NZ NZ524030A patent/NZ524030A/en unknown
- 2001-08-03 CN CN01815600A patent/CN1455778A/zh active Pending
- 2001-08-03 HU HU0300778A patent/HUP0300778A3/hu unknown
- 2001-08-03 DE DE60132461T patent/DE60132461T2/de not_active Expired - Fee Related
- 2001-08-03 YU YU14603A patent/YU14603A/sh unknown
- 2001-08-03 CZ CZ2003313A patent/CZ2003313A3/cs unknown
- 2001-08-03 JP JP2002518207A patent/JP2004505970A/ja not_active Withdrawn
- 2001-08-03 EP EP01954159A patent/EP1305311B1/fr not_active Expired - Lifetime
- 2001-08-03 DZ DZ013418A patent/DZ3418A1/fr active
2003
- 2003-02-03 NO NO20030530A patent/NO324596B1/no not_active IP Right Cessation
- 2003-02-03 IL IL154275A patent/IL154275A/en not_active IP Right Cessation
- 2003-02-03 MA MA27024A patent/MA25832A1/fr unknown
- 2003-02-04 ZA ZA200300961A patent/ZA200300961B/en unknown
- 2003-02-04 EC EC2003004467A patent/ECSP034467A/es unknown
- 2003-02-28 BG BG107604A patent/BG107604A/bg unknown
2008
- 2008-03-19 CY CY20081100309T patent/CY1107252T1/el unknown

Also Published As

Publication number	Publication date
EA005408B1 (ru)	2005-02-24
ES2296772T3 (es)	2008-05-01
KR100755174B1 (ko)	2007-09-03
NZ524030A (en)	2004-07-30
EP1305311A1 (fr)	2003-05-02
CZ2003313A3 (cs)	2004-02-18
HRP20030068A2 (en)	2005-02-28
US20040014790A1 (en)	2004-01-22
YU14603A (sh)	2006-05-25
DZ3418A1 (fr)	2002-02-14
NO20030530L (no)	2003-02-03
MXPA03001085A (es)	2003-05-27
NO20030530D0 (no)	2003-02-03
HUP0300778A3 (en)	2005-04-28
EP1305311B1 (fr)	2008-01-16
DE60132461T2 (de)	2008-12-24
AU2001276506A1 (en)	2002-02-18
CA2417827A1 (fr)	2002-02-14
PL360662A1 (en)	2004-09-20
HUP0300778A2 (hu)	2003-11-28
HRP20030068B1 (en)	2008-07-31
PT1305311E (pt)	2008-04-07
DK1305311T3 (da)	2008-05-19
CN1455778A (zh)	2003-11-12
EA200300230A1 (ru)	2003-06-26
OA12354A (en)	2004-03-19
IL154275A (en)	2009-02-11
WO2002012232A1 (fr)	2002-02-14
GB0019224D0 (en)	2000-09-27
DE60132461D1 (de)	2008-03-06
SK1462003A3 (en)	2004-06-08
IL154275A0 (en)	2003-09-17
BG107604A (bg)	2003-09-30
ZA200300961B (en)	2004-04-01
HK1057358A1 (en)	2004-04-02
AP1785A (en)	2007-10-04
CY1107252T1 (el)	2012-11-21
ATE384059T1 (de)	2008-02-15
BR0112982A (pt)	2003-08-26
KR20030022355A (ko)	2003-03-15
SI1305311T1 (sl)	2008-04-30
AP2003002736A0 (en)	2003-03-31
JP2004505970A (ja)	2004-02-26
UA76720C2 (uk)	2006-09-15
NO324596B1 (no)	2007-11-26
ECSP034467A (es)	2003-03-31

Publication	Publication Date	Title
LU92678I2 (fr)	2015-11-02	Tobramycine ou un sel pharmaceutiquement acceptable qui en dérive
LU93266I2 (fr)	2016-12-19	Sélexipag ou un sel de celui-ci
LU92702I2 (fr)	2016-07-29	Naloxegol ou un sel pharmaceutiquement acceptable de celui-ci (moventig)
BR0000327B1 (pt)	2008-11-18	cabeÇa de poÇo.
ATE414079T1 (de)	2008-11-15	2,4-disubstituierte thiazolyl derivate
DZ3001A1 (fr)	2004-03-27	Sel de potassium d'oméprazole-(S).
DE60137416D1 (de)	2009-03-05	Panoramakopf
MA25898A1 (fr)	2003-10-01	SELS DE TARTRATE D'UN DERIVé DE THIAZOLIDINEDIONE.
MA25830A1 (fr)	2003-07-01	Sel de tartrate d'un derive de thiazolidinedione.
EG22745A (en)	2003-07-30	2-(3,5-Disbustituted-4-pyridyl)-4-(thienyl) thiazolyl or arylphenyl)1,30xazoline compounds
MA25831A1 (fr)	2003-07-01	Sel de tartrate d'un derive de thiazolidinedione.
DE60132461D1 (de)	2008-03-06	Tartratsalze eines thiazolidinedione derivats
ZA200205835B (en)	2003-07-22	Compounds useful for the treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor.
FR2818104B3 (fr)	2004-10-29	Latte perfectionnee pour sommier
HRP20020746A2 (en)	2004-12-31	Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
FR2809397B1 (fr)	2002-07-19	Procede de preparation d'un compose de type benzofuranne ou benzothiophene
SI1305310T1 (sl)	2008-06-30	Tartratne soli derivata tiazolidindiona
IT1311483B1 (it)	2002-03-13	Tavolo per un gioco di bilie.
ITRM20040312A1 (it)	2004-09-24	Scatola perfezionata per capi d'abbigliamento.
IT250149Y1 (it)	2003-07-24	Dispositivo per l'applicazione di un prodotto
IT1314214B1 (it)	2002-12-06	Forma per getti di colatura.
FR2826662B1 (fr)	2003-11-07	Procede de preparation d'un sel de polyaniline
ITBO20020704A1 (it)	2004-05-07	Macchina, utilizzante cialde, per l'erogazione di
IT249798Y1 (it)	2003-05-28	Soffione per doccia ispezionabile